1.        Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1       Middle East & Africa RNAi Therapeutics Market – By Molecule Type

1.3.2       Middle East & Africa RNAi Therapeutics Market – By Application

1.3.3       Middle East & Africa RNAi Therapeutics Market – By Route of Administration

1.3.4       Middle East & Africa RNAi Therapeutics Market– By End User

1.3.5       Middle East & Africa RNAi Therapeutics Market – By Country

2.        Middle East & Africa RNAi Therapeutics Market – Key Takeaways

3.        Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.        Middle East & Africa RNAi Therapeutics Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1       RNAi therapeutics Market - Middle East & Africa PEST Analysis

4.3       Expert Opinion

5.        Middle East & Africa RNAi Therapeutics Market - Key Market Dynamics

5.1       Key Market Drivers

5.1.1       Growing Investments in RNAi Therapies

5.1.2       Rising Prevalence of Chronic Conditions and Infectious Diseases

5.2       Market Restraints

5.2.1       High Cost for RNAi Therapy Development

5.3       Market Opportunities

5.3.1       Significant Number of Pipeline Candidates for Strategic Alliances

5.4       Future Trends

5.4.1       Rising Emphasis on RNA Technologies

5.5       Impact analysis

6.        RNAi Therapeutics Market – Middle East & Africa Analysis

6.1       Middle East & Africa RNAi Therapeutics Market Revenue Forecasts and Analysis

7.        Middle East & Africa RNAi Therapeutics Market Analysis and Forecasts To 2027 – By Molecule Type

7.1       Overview

7.2       Middle East & Africa RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)

7.2.1       Middle East & Africa RNAi therapeutics Market Revenue and Forecasts to 2027, By Molecule Type (US$ Mn)

7.3       Small Interfering RNAs (siRNA)

7.3.1       Overview

7.3.2       Middle East & Africa Small Interfering RNAs (siRNA) Market Revenue and Forecast to 2027 (US$ Mn)

7.4       MicroRNA (miRNA)

7.4.1       Overview

7.4.2       Middle East & Africa MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

8.        Middle East & Africa RNAi therapeutics Market Analysis and Forecasts To 2027 – By Application

8.1       Overview

8.2       Middle East & Africa RNAi therapeutics Market, By Application 2019 & 2027 (%)

8.2.1       Middle East & Africa RNAi therapeutics Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3       Genetic Disorders

8.3.1       Overview

8.3.2       Middle East & Africa Genetic Disorders Market Revenue and Forecast to 2027 (US$ Mn)

8.4       Oncology

8.4.1       Overview

8.4.2       Middle East & Africa Oncology Market Revenue and Forecasts to 2027 (US$ Mn)

8.5       Neurodegenerative Disorders

8.5.1       Overview

8.5.2       Middle East & Africa Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

8.6       Cardiovascular Disorders

8.6.1       Overview

8.6.2       Middle East & Africa Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

8.7       Respiratory Disorders

8.7.1       Overview

8.7.2       Middle East & Africa Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

8.8       Infectious Diseases

8.8.1       Overview

8.8.2       Middle East & Africa Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

8.9       Renal Diseases

8.9.1       Overview

8.9.2       Middle East & Africa Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

8.10     Other Disorders

8.10.1    Overview

8.10.2    Middle East & Africa Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

9.        Middle East & Africa RNAi therapeutics Market Analysis and Forecasts To 2027 – By Route of Administration

9.1       Overview

9.2       Middle East & Africa RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)

9.2.1       Middle East & Africa RNAi therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

9.3       Intradermal Injections

9.3.1       Overview

9.3.2       Middle East & Africa Intradermal Injections Market Revenue and Forecast to 2027 (US$ Mn)

9.4       Pulmonary Delivery

9.4.1       Overview

9.4.2       Middle East & Africa Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

9.5       Intravenous Injections

9.5.1       Overview

9.5.2       Middle East & Africa Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)

9.6       Intraperitoneal Injections

9.6.1       Overview

9.6.2       Middle East & Africa Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)

9.7       Other Route of Administrations

9.7.1       Overview

9.7.2       Middle East & Africa Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)

10.      Middle East & Africa RNAi Therapeutics Market Analysis – By End-User

10.1     Overview

10.2     Middle East & Africa RNAi Therapeutics Market, By End-User 2019-2027 (%)

10.2.1    Middle East & Africa RNAi Therapeutics Market Revenue and Forecasts to 2027, By End-User (US$ Mn)

10.3     Diagnostic Laboratories

10.3.1    Overview

10.3.2    Middle East & Africa Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

10.4     Research and Academic Laboratories

10.4.1    Overview

10.4.2    Middle East & Africa Research and Academic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

10.5     Hospitals

10.5.1    Overview

10.5.2    Middle East & Africa Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

11.      RNAi therapeutics Market Revenue and Forecasts To 2027 – Geographical Analysis

11.1     Middle East & Africa: RNAi Therapeutics Market

11.1.1    Overview

11.1.2    Middle East & Africa: RNAi Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)

11.1.3    Middle East & Africa: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)

11.1.4    Middle East & Africa RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027  (USD Million)

11.1.5    Middle East & Africa: RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.6    Middle East & Africa RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027  (USD Million)

11.1.7    Middle East & Africa: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)

11.1.8    Saudi Arabia: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1      Saudi Arabia: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2      Saudi Arabia: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)

11.1.8.3      Saudi Arabia RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.8.4      Saudi Arabia: RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.8.5      Saudi Arabia RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.9    UAE: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1      UAE: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2      UAE: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)

11.1.9.3      UAE RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.9.4      UAE: RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.9.5      UAE RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.10  South Africa: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1    South Africa: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2    South Africa: RNAi Therapeutics Market, by Molecule Type, 2018–2027 (USD Million)

11.1.10.3    South Africa RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.10.4    South Africa RNAi Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.10.5    South Africa RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

12.      Impact of COVID-19 Pandemic on Middle East & Africa RNAi therapeutics Market

12.1     Middle East & Africa: Impact Assessment of COVID-19 Pandemic

13.      Company Profiles

13.1     Benitec Biopharma

13.1.1    Key Facts

13.1.2    Business Description

13.1.3    Products and Services

13.1.4    Financial Overview

13.1.5    SWOT Analysis

13.1.6    Key Developments

13.2     Olix Pharmaceuticals, Inc.

13.2.1    Key Facts

13.2.2    Business Description

13.2.3    Products and Services

13.2.4    Financial Overview

13.2.5    SWOT Analysis

13.2.6    Key Developments

13.3     GlaxoSmithKline plc.

13.3.1    Key Facts

13.3.2    Business Description

13.3.3    Products and Services

13.3.4    Financial Overview

13.3.5    SWOT Analysis

13.3.6    Key Developments

13.4     Alnylam Pharmaceuticals, Inc.

13.4.1    Key Facts

13.4.2    Business Description

13.4.3    Products and Services

13.4.4    Financial Overview

13.4.5    SWOT Analysis

13.4.6    Key Developments

13.5     Arrowhead Pharmaceuticals, Inc

13.5.1    Key Facts

13.5.2    Business Description

13.5.3    Products and Services

13.5.4    Financial Overview

13.5.5    SWOT Analysis

13.5.6    Key Developments

14.      Appendix

14.1     About The Insight Partners

14.2     Glossary of Terms

Table 1.          Middle East & Africa RNAi therapeutics Market Revenue and Forecasts To 2027, By Molecule Type (US$ Mn)

Table 2.          Middle East & Africa RNAi therapeutics Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3.          Middle East & Africa RNAi therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

Table 4.          Middle East & Africa RNAi Therapeutics Market Revenue and Forecasts To 2027, By End-User (US$ Mn)

Table 5.          Middle East & Africa RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027  (USD Million)

Table 6.          Middle East & Africa RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 7.          Middle East & Africa RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 8.          Middle East & Africa RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 9.          Saudi Arabia RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 10.        Saudi Arabia RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.        Saudi Arabia RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 12.        Saudi Arabia RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.        UAE RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 14.        UAE RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.        UAE RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 16.        UAE RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 17.        South Africa RNAi Therapeutics Market, by Molecule Type – Revenue and Forecast to 2027 (USD Million)

Table 18.        South Africa RNAi Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 19.        South Africa RNAi Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 20.        South Africa RNAi Therapeutics Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21.        Glossary of Terms, RNAi Therapeutics Market

Figure 1.         RNAi Therapeutics Market Segmentation

Figure 2.         Middle East & Africa RNAi Therapeutics Market Overview

Figure 3.         Small Interfering RNAs (siRNA) Molecule Type Segment Held Largest Share of RNAi Therapeutics Market

Figure 4.         UAE is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.         Middle East & Africa RNAi Therapeutics Market - Leading Country Markets (US$ Mn)

Figure 6.         RNAi Therapeutics Market - Middle East & Africa PEST Analysis

Figure 7.         RNAi Therapeutics Market Impact Analysis of Driver and Restraints

Figure 8.         Middle East & Africa RNAi Therapeutics Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.         Middle East & Africa RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)

Figure 10.       Middle East & Africa Small Interfering RNAs (siRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.       Middle East & Africa MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.       Middle East & Africa RNAi therapeutics Market, By Application 2019 & 2027 (%)

Figure 13.       Middle East & Africa Genetic Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.       Middle East & Africa Oncology Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.       Middle East & Africa Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.       Middle East & Africa Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.       Middle East & Africa Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.       Middle East & Africa Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.       Middle East & Africa Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.       Middle East & Africa Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.       Middle East & Africa RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)

Figure 22.       Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.       Middle East & Africa Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.       Middle East & Africa Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.       Middle East & Africa Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.       Middle East & Africa Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.       Middle East & Africa RNAi Therapeutics Market, by End-User 2019 & 2027 (%)

Figure 28.       Middle East & Africa Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.       Middle East & Africa Research and Academic Laboratories Mark et Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.       Middle East & Africa Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31.       Middle East & Africa: RNAi Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

Figure 32.       Middle East & Africa RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)

Figure 33.       Middle East & Africa: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)

Figure 34.       Saudi Arabia: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.       UAE: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.       South Africa: RNAi Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.       Impact of COVID-19 Pandemic in Middle East & Africa Country Markets